Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT00223418
Eligibility Criteria:
Inclusion Criteria:
* DSM-IV diagnosis of schizophrenia or schizoaffective disorder
* Between ages of 18 and 52
* On olanzapine for a minimum of 3 months prior to participation
* Outpatient status for at least 3 months
* Vision and hearing intact or corrected to extent that will allow participation in vocational training and cognitive testing
* Score in impaired range on at least one test from a cognitive battery designed to be sensitive to impairments in schizophrenia
* Ability to participate in the informed consent process, as evidenced by an assessment of the capacity to give consent for research developed by the Maryland Psychiatric Research Center (DeRenzo et al., 1998).
Exclusion Criteria:
* History of head injury, mental retardation or neurological disorder
* Below a 4th grade reading level (32) according to the WRAT-3
* Taking multiple atypical antipsychotics
* Taking any decanoate antipsychotic
* Hospitalization in last 3 months
* Employment
* Alcohol or drug abuse that interferes with functioning or medication compliance
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
52 Years
Study:
NCT00223418
Study Brief:
Protocol Section:
NCT00223418